Cargando…
Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future
Malaria is still one of the major killer parasitic diseases in tropical settings, posing a public health threat. The development of antimalarial drug resistance is reversing the gains made in attempts to control the disease. The parasite leads a complex life cycle that has adapted to outwit almost a...
Autores principales: | Stofberg, Melissa Louise, Caillet, Celine, de Villiers, Marianne, Zininga, Tawanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616389/ https://www.ncbi.nlm.nih.gov/pubmed/34831072 http://dx.doi.org/10.3390/cells10112849 |
Ejemplares similares
-
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance
por: Shahinas, Dea, et al.
Publicado: (2013) -
Host cell stress response as a predictor of COVID-19 infectivity and disease progression
por: Caillet, Celine, et al.
Publicado: (2022) -
Inhibition of Plasmodium falciparum Hsp70-Hop partnership by 2-phenylthynesulfonamide
por: Muthelo, Tshifhiwa, et al.
Publicado: (2022) -
Comparative structure-function features of Hsp70s of Plasmodium falciparum and human origins
por: Chakafana, Graham, et al.
Publicado: (2019) -
Biophysical analysis of Plasmodium falciparum Hsp70-Hsp90 organising protein (PfHop) reveals a monomer that is characterised by folded segments connected by flexible linkers
por: Makumire, Stanley, et al.
Publicado: (2020)